PubRank

J A McKnight

Author PubWeight™ 33.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013 2.31
2 Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin. Diabet Med 2007 2.21
3 Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 2011 2.12
4 External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med 2013 1.90
5 Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM 2000 1.84
6 Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 2005 1.59
7 Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabet Med 2014 1.49
8 Ambulatory blood pressure monitoring: is it necessary for the routine assessment of hypertension in people with diabetes? Diabet Med 2002 1.47
9 Assessment of the under-reporting of diabetes in hospital admission data: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabet Med 2011 1.23
10 Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score. Diabet Med 2006 1.20
11 Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clin Endocrinol (Oxf) 1996 1.16
12 Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 2012 1.11
13 Lowering serum urate does not improve endothelial function in patients with type 2 diabetes. Diabetologia 2007 0.96
14 Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia 2006 0.94
15 Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997 0.93
16 Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia 2012 0.91
17 A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clin Endocrinol (Oxf) 1994 0.88
18 Preservation of vascular function in rat mesenteric resistance arteries following cold storage, studied by small vessel myography. Br J Pharmacol 1998 0.85
19 Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2011 0.85
20 The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia 2012 0.83
21 Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries. Br J Pharmacol 2001 0.80
22 Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007. Diabetologia 2013 0.79
23 Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type I diabetes. Clin Sci (Lond) 2001 0.79
24 Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas. QJM 1999 0.78
25 Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997-2004). Vet Comp Oncol 2007 0.78
26 The oxidation of proline by mitochondrial preparations. Comp Biochem Physiol B 1986 0.78
27 Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens 1996 0.78
28 Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002). Vet Comp Oncol 2007 0.77
29 Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 1994 0.76
30 Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter]. Diabetologia 2013 0.75
31 Dietary factors and blood pressure regulation. Endocrinol Metab Clin North Am 1995 0.75
32 Somatostatin analogue (SMS 201-995) in resistant acromegaly: a preliminary report. Horm Res 1990 0.75
33 Relapsing polychondritis--case report. Ir Med J 1985 0.75
34 Prevalence of hypertension and albuminuria in a teaching hospital diabetes clinic. Diabetes Res Clin Pract 1995 0.75
35 Variations in the plasma concentration of atrial natriuretic factor across 24 hours. Acta Endocrinol (Copenh) 1989 0.75
36 Plasma atrial natriuretic factor levels during normal pregnancy and pregnancy complicated by diabetes mellitus and hypertension. J Hum Hypertens 1990 0.75
37 Assessing vascular risk in people with Type 1 diabetes. Diabet Med 2007 0.75
38 Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: A retrospective analysis of 12 cases (1997-2002)*. Vet Comp Oncol 2005 0.75
39 The growth hormone response to growth hormone releasing hormone in patients previously treated with bilateral adrenalectomy alone for Cushing's disease. J Endocrinol Invest 1990 0.75
40 Weight loss and fatigue in an elderly patient. Scott Med J 2005 0.75